Septerna (SEPN) Deferred Taxes (2024)
Septerna's quarterly Deferred Taxes came in at -$153000.0 in Q4 2024, down 12.5% quarter-over-quarter from -$136000.0 in Q3 2024.
Septerna has reported Deferred Taxes for 1 years, with the latest figure at -$153000.0 in Q4 2024.
- For the quarter ending Q4 2024, Deferred Taxes changed N/A year-over-year to -$153000.0; the trailing twelve-month figure through Dec 2024 stood at -$491000.0 (changed N/A YoY), and the FY2024 full-year result was -$491000.0, down 200.0% from the prior year.
- Deferred Taxes for Q4 2024 stood at -$153000.0, down from -$136000.0 in the prior quarter.
- The five-year high for Deferred Taxes was -$93000.0 in Q1 2024, with the low at -$153000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -153,000.00 |
| Sep 30, 2024 | -136,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | -93,000.00 |